Small molecule screen for compounds that affect vascular development in the zebrafish retina

Area of Science:

• Ophthalmology
• Developmental Biology
• Pharmacology

Background:

• Blood vessel formation (angiogenesis) in the vertebrate eye is critical for vision.
• Dysregulation of retinal vasculature, including excess or deficiency, can cause vision loss.
• Understanding the molecular basis of retinal angiogenesis is key to developing treatments.

Purpose of the Study:

• To investigate the molecular mechanisms of blood vessel formation in the embryonic zebrafish eye.
• To identify small molecules that modulate eye vasculature development.
• To explore potential pharmacological interventions for vision-threatening vascular conditions.

Main Methods:

• Characterization of embryonic zebrafish eye vasculature.
• High-throughput screening of approximately 2000 small molecules.
• Assessment of compound effects on retinal and trunk vasculature morphology.
• Evaluation of compound impact on neuronal architecture.

Main Results:

• Four small molecules were identified that specifically alter retinal vessel morphology.
• Two compounds caused vessel widening without significant loss of vessel number.
• One compound induced vessel loss with mild diameter increase; another caused severe vessel loss.
• Identified compounds did not overtly affect trunk vessels or retinal neuronal architecture.

Conclusions:

• Zebrafish serve as an effective model for screening small molecules targeting eye vasculature.
• Several identified compounds demonstrate potential for therapeutic applications in managing retinal vascular diseases.
• This study provides novel small molecules for further investigation into controlling angiogenesis in the eye.